1,152 results on '"Clemens, J Quentin"'
Search Results
2. Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study
- Author
-
Stephens-Shields, Alisa J, Lai, H Henry, Landis, J Richard, Kreder, Karl, Rodriguez, Larissa V, Naliboff, Bruce D, Afari, Niloofar, Sutcliffe, Siobhan, Moldwin, Robert, Griffith, James W, Clemens, J Quentin, Bradley, Catherine S, Quallich, Susan, Gupta, Priyanka, Harte, Steven E, and Farrar, John T
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Chronic Pain ,Pain Research ,Clinical Research ,Urologic Diseases ,Management of diseases and conditions ,7.3 Management and decision making ,Renal and urogenital ,Humans ,Male ,Female ,Prostatitis ,Pelvic Pain ,Cystitis ,Interstitial ,Depression ,minimal clinically important difference ,treatment outcome ,research design ,pelvic pain ,cystitis ,interstitial ,cystitis ,interstitial - Abstract
PurposeSymptom heterogeneity in interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome, collectively termed urological chronic pelvic pain syndrome, has resulted in difficulty in defining appropriate clinical trial endpoints. We determine clinically important differences for 2 primary symptom measures, pelvic pain severity and urinary symptom severity, and evaluate subgroup differences.Materials and methodsThe Multidisciplinary Approach to the Study of Chronic Pelvic Pain Symptom Patterns Study enrolled individuals with urological chronic pelvic pain syndrome. We defined clinically important differences by associating changes in pelvic pain severity and urinary symptom severity over 3 to 6 months with marked improvement on a global response assessment using regression and receiver operating characteristic curves. We evaluated clinically important differences for absolute and percent change and examined differences in clinically important differences by sex-diagnosis, presence of Hunner lesions, pain type, pain widespreadness, and baseline symptom severity.ResultsAn absolute change of -4 was clinically important in pelvic pain severity among all patients, but clinically important difference estimates differed by pain type, presence of Hunner lesions, and baseline severity. Pelvic pain severity clinically important difference estimates for percent change were more consistent across subgroups and ranged from 30% to 57%. The absolute change urinary symptom severity clinically important difference was -3 for female participants and -2 for male participants with chronic prostatitis/chronic pelvic pain syndrome only. Patients with greater baseline severity required larger decreases in symptoms to feel improved. Estimated clinically important differences had lower accuracy among participants with low baseline symptoms.ConclusionsA reduction of 30%-50% in pelvic pain severity is a clinically meaningful endpoint for future therapeutic trials in urological chronic pelvic pain syndrome. Urinary symptom severity clinically important differences are more appropriately defined separately for male and female participants.
- Published
- 2023
3. Perceived vs Actual Shared Decision-Making Behavior Among Urologists: A Convergent, Parallel, Mixed-Methods Study of Self-Reported Practice
- Author
-
Ippolito, Giulia M., Reines, Katy, Meeks, William D., Mbassa, Rachel, Ellimoottil, Chad, Faris, Anna, Reuland, Daniel S., Nielsen, Matthew E., Teal, Randall, Vu, Maihan, Clemens, J. Quentin, and Tan, Hung-Jui
- Published
- 2024
- Full Text
- View/download PDF
4. Summary of the 2023 report of the international consultation on incontinence interstitial cystitis/bladder pain syndrome (IC/BPS) committee
- Author
-
Hanno, Philip, Cervigni, Mauro, Choo, Myung Soo, Clemens, J. Quentin, Lee, Ming-Huei, Malde, Sachin, Meijlink, Jane, Samarinas, Michael, Ueda, Tomohiro, and Gold, Daniela
- Published
- 2023
- Full Text
- View/download PDF
5. Infection and Inflammation of the Genitourinary Tract
- Author
-
Clemens, J. Quentin, primary
- Published
- 2024
- Full Text
- View/download PDF
6. PD43-01 STRUCTURAL CHANGES IN BRAIN WHITE MATTER TRACTS ASSOCIATED WITH OVERACTIVE BLADDER REVEALED BY DIFFUSION TENSOR MRI: FINDINGS FROM THE LURN STUDY
- Author
-
Lai, H. Henry, primary, Rutlin, Jerrel, additional, Smith, Abigail R., additional, Helmuth, Margaret E., additional, Hokanson, James A., additional, Yang, Claire C., additional, Clemens, J. Quentin, additional, Magnotta, Vincent A., additional, Bretschneider, C. Emi, additional, Kenton, Kimberly, additional, DeLancey, John O. L., additional, John, Karen, additional, Kirkali, Ziya, additional, and Shimony, Joshua S., additional
- Published
- 2024
- Full Text
- View/download PDF
7. Cognitive Behavioral Therapy for Chronic Pelvic Pain: What Is It and Does It Work?
- Author
-
Lackner, Jeffrey M., primary, Clemens, J. Quentin, additional, Radziwon, Christopher, additional, Danforth, Teresa L., additional, Ablove, Tova S., additional, Krasner, Susan S., additional, Vargovich, Alison M., additional, O’Leary, Patricia C., additional, Marotto, Tracy, additional, and Naliboff, Bruce D., additional
- Published
- 2024
- Full Text
- View/download PDF
8. Long-Term Symptom Trajectories in Urologic Chronic Pelvic Pain Syndrome: A MAPP Research Network Study
- Author
-
Bradley, Catherine S., Gallop, Robert, Sutcliffe, Siobhan, Kreder, Karl J., Lai, H. Henry, Clemens, J. Quentin, and Naliboff, Bruce D.
- Published
- 2022
- Full Text
- View/download PDF
9. Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network
- Author
-
Clemens, J Quentin, Mullins, Chris, Ackerman, A Lenore, Bavendam, Tamara, van Bokhoven, Adrie, Ellingson, Benjamin M, Harte, Steven E, Kutch, Jason J, Lai, H Henry, Martucci, Katherine T, Moldwin, Robert, Naliboff, Bruce D, Pontari, Michel A, Sutcliffe, Siobhan, and Landis, J Richard
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Urologic Diseases ,Pain Research ,Clinical Research ,Chronic Pain ,Renal and urogenital ,Biomedical Research ,Cystitis ,Interstitial ,Humans ,Interdisciplinary Research ,Male ,Pelvic Pain ,Prostatitis ,Syndrome ,MAPP Research Network Study Group ,Urology & Nephrology ,Clinical sciences - Abstract
Urologic chronic pelvic pain syndrome (UCPPS), which encompasses interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome, is characterized by chronic pain in the pelvic region or genitalia that is often accompanied by urinary frequency and urgency. Despite considerable research, no definite aetiological risk factors or effective treatments have been identified. The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network uses a novel integrated strategy to characterize UCPPS as a systemic disorder that potentially involves multiple aetiologies. The first phase, MAPP I, included >1,000 participants who completed an intensive baseline assessment followed by a 12-month observational follow-up period. MAPP I studies showed that UCPPS pain and urinary symptoms co-vary, with only moderate correlation, and should be evaluated separately and that symptom flares are common and can differ considerably in intensity, duration and influence on quality of life. Longitudinal clinical changes in UCPPS correlated with structural and functional brain changes, and many patients experienced global multisensory hypersensitivity. Additionally, UCPPS symptom profiles were distinguishable by biological correlates, such as immune factors. These findings indicate that patients with UCPPS have objective phenotypic abnormalities and distinct biological characteristics, providing a new foundation for the study and clinical management of UCPPS.
- Published
- 2019
10. Sensory sensitivity and symptom severity represent unique dimensions of chronic pain
- Author
-
Schrepf, Andrew, Williams, David A, Gallop, Robert, Naliboff, Bruce D, Basu, Neil, Kaplan, Chelsea, Harper, Daniel E, Landis, J Richard, Clemens, J Quentin, Strachan, Eric, Griffith, James W, Afari, Niloofar, Hassett, Afton, Pontari, Michel A, Clauw, Daniel J, and Harte, Steven E
- Subjects
Neurosciences ,Chronic Pain ,Clinical Research ,Urologic Diseases ,Peripheral Neuropathy ,Pain Research ,Neurological ,Adult ,Biomedical Research ,Cohort Studies ,Connectome ,Factor Analysis ,Statistical ,Female ,Humans ,Interdisciplinary Communication ,Male ,National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) ,Pelvic Pain ,United States ,Interstitial cystitis/painful bladder syndrome ,Factor analysis ,statistical ,Fibromyalgia ,Central nervous system sensitization ,Interoception ,MAPP Research Network ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Anesthesiology - Abstract
Chronic overlapping pain conditions (COPCs) are characterized by aberrant central nervous system processing of pain. This "centralized pain" phenotype has been described using a large and diverse set of symptom domains, including the spatial distribution of pain, pain intensity, fatigue, mood imbalances, cognitive dysfunction, altered somatic sensations, and hypersensitivity to external stimuli. Here, we used 3 cohorts, including patients with urologic chronic pelvic pain syndrome, a mixed pain cohort with other COPCs, and healthy individuals (total n = 1039) from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network to explore the factor structure of symptoms of centralized pain. Using exploratory and confirmatory factor analysis, we identified 2 general factors in all 3 cohorts, one characterized by a broad increased sensitivity to internal somatic sensations,environmental stimuli, and diffuse pain, termed Generalized Sensory Sensitivity, and one characterized by constitutional symptoms-Sleep, Pain, Affect, Cognition, Energy (SPACE). Longitudinal analyses in the urologic chronic pelvic pain syndrome cohort found the same 2-factor structure at month 6 and 1 year, suggesting that the 2-factor structure is reproducible over time. In secondary analyses, we found that Generalized Sensory Sensitivity particularly is associated with the presence of comorbid COPCs, whereas SPACE shows modest associations with measures of disability and urinary symptoms. These factors may represent an important and distinct continuum of symptoms that are indicative of the centralized pain phenotype at high levels. Future research of COPCs should accommodate the measurement of each factor.
- Published
- 2018
11. Study protocol and methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a randomized clinical trial of brief, low-intensity, transdiagnostic cognitive behavioral therapy vs education/support for urologic chronic pelvic pain syndrome (UCPPS)
- Author
-
Lackner, Jeffrey M., Jaccard, James, Quigley, Brian M., Ablove, Tova S., Danforth, Teresa L., Firth, Rebecca S., Gudleski, Gregory D., Krasner, Susan S., Radziwon, Christopher D., Vargovich, Alison M., Clemens, J. Quentin, and Naliboff, Bruce D.
- Published
- 2022
- Full Text
- View/download PDF
12. Stimulated whole-blood cytokine/chemokine responses are associated with interstitial cystitis/bladder pain syndrome phenotypes and features of nociplastic pain: a multidisciplinary approach to the study of chronic pelvic pain research network study
- Author
-
Schrepf, Andrew, Kaplan, Chelsea, Harris, Richard E., Williams, David A., Clauw, Daniel J., As-Sanie, Sawsan, Till, Sara, Clemens, J. Quentin, Rodriguez, Larissa V., Van Bokhoven, Adrie, Landis, Richard, Gallop, Robert, Bradley, Catherine, Naliboff, Bruce, Pontari, Mike, OʼDonnell, Michael, Luo, Yi, Kreder, Karl, Lutgendorf, Susan K., and Harte, Steven E.
- Published
- 2022
- Full Text
- View/download PDF
13. Use of the American Urological Association Clinical Practice Guidelines: Data from the AUA Census
- Author
-
Breyer, Benjamin N, Fang, Raymond, Meeks, William, Lightner, Deborah, and Clemens, J Quentin
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Health Sciences ,Urologic Diseases ,Clinical Research ,Cancer ,Management of diseases and conditions ,7.3 Management and decision making ,censuses ,practice guidelines as topic ,urology ,Clinical sciences ,Public health - Abstract
IntroductionThrough systematic data review and expert consensus, the AUA (American Urological Association) produces clinical practice guidelines that serve to provide evidence-based guidance with an explicit clinical scope and purpose. In this study we determined whether urologists use clinical practice guidelines when making clinical decisions, and whether demographic factors are associated with not using the guidelines or with a lack of guideline awareness.MethodsWe examined the 2014 AUA Census. Our outcome was a question regarding whether the participant used AUA clinical practice guidelines in clinical decision making. We performed comparative statistical analyses, stratifying our outcome by demographic and practice specific variables.ResultsA total of 2,204 urologists completed the census, representing 18.9% of practicing urologists in the United States. Median age was 53 years and 91.1% were male. The majority of urologists used clinical practice guidelines (94.8%) in clinical decision making. Clinical practice guidelines had the lowest use among urologists 65 years old or older (89.2%), those in solo practice (88.3%) and pediatric specialists (87.9%). Based on a multivariable logistic regression analysis, factors associated with not using clinical practice guidelines included increasing age, metropolitan practice setting and solo practice. Gender, AUA section, level of rurality and fellowship training were not statistically associated with clinical practice guideline use.ConclusionsThe majority of urologists (approximately 95%) use AUA clinical practice guidelines to inform clinical decisions. Our findings support the importance of clinical practice guidelines and highlight potential opportunities for better targeted outreach to improve clinical practice guideline use among practicing urologists.
- Published
- 2017
14. Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network
- Author
-
Naliboff, Bruce D, Stephens, Alisa J, Lai, H Henry, Griffith, James W, Clemens, J Quentin, Lutgendorf, Susan, Rodriguez, Larissa V, Newcomb, Craig, Sutcliffe, Siobhan, Guo, Wensheng, Kusek, John W, Landis, J Richard, and Network, MAPP Research
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Pain Research ,Mental Health ,Depression ,Chronic Pain ,Urologic Diseases ,Good Health and Well Being ,Adult ,Anxiety ,Catastrophization ,Female ,Humans ,Lower Urinary Tract Symptoms ,Male ,Middle Aged ,Pain Measurement ,Patient Reported Outcome Measures ,Pelvic Pain ,Prognosis ,Prospective Studies ,Psychological Tests ,Psychometrics ,Self Report ,Severity of Illness Index ,Sex Factors ,Syndrome ,Time Factors ,United States ,urinary bladder ,prostate ,prostatitis ,cystitis ,interstitial ,pelvic pain ,MAPP Research Network - Abstract
PurposeWe examined baseline clinical and psychosocial characteristics that predict 12-month symptom change in men and women with urological chronic pelvic pain syndromes.Materials and methodsA total of 221 female and 176 male patients with urological chronic pelvic pain syndromes were recruited from 6 academic medical centers in the United States and evaluated at baseline with a comprehensive battery of symptom, psychosocial and illness-impact measures. Based on biweekly symptom reports, a functional clustering procedure classified participant outcome as worse, stable or improved on pain and urinary symptom severity. Cumulative logistic modeling was used to examine individual predictors associated with symptom change as well as multiple predictor combinations and interactions.ResultsAbout 60% of participants had stable symptoms with smaller numbers (13% to 22%) showing clear symptom worsening or improvement. For pain and urinary outcomes the extent of widespread pain, amount of nonurological symptoms and poorer overall health were predictive of worsening outcomes. Anxiety, depression and general mental health were not significant predictors of outcomes but pain catastrophizing and self-reported stress were associated with pain outcome. Prediction models did not differ between men and women and for the most part they were independent of symptom duration and age.ConclusionsThese results demonstrate for the first time in a large multisite prospective study that presence of widespread pain, nonurological symptoms and poorer general health are risk factors for poorer pain and urinary outcomes in men and women. The results point to the importance of broad based assessment for urological chronic pelvic pain syndromes and future studies of the mechanisms that underlie these findings.
- Published
- 2017
15. Editorial
- Author
-
Ginsberg, David A., primary, Clemens, J. Quentin, additional, Cameron, Anne P., additional, Vasavada, Sandip P., additional, and Wein, Alan J., additional
- Published
- 2024
- Full Text
- View/download PDF
16. Neuroanatomy of Bladder Pain
- Author
-
Sheetz, Tyler, Clemens, J. Quentin, and Crescenze, Irene
- Published
- 2021
- Full Text
- View/download PDF
17. The Value of Urodynamics in an Academic Specialty Referral Practice
- Author
-
Suskind, Anne M, Cox, Lindsey, Clemens, J Quentin, Oldendorf, Ann, Stoffel, John T, Malaeb, Bahaa, Qin, Yongmei, and Cameron, Anne P
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Urologic Diseases ,Clinical Research ,Renal and urogenital ,Adolescent ,Adult ,Aged ,Aged ,80 and over ,Female ,Humans ,Male ,Middle Aged ,Patient Selection ,Practice Patterns ,Physicians' ,Referral and Consultation ,Surveys and Questionnaires ,Urination Disorders ,Urodynamics ,Urology ,Young Adult ,Clinical Sciences ,Urology & Nephrology ,Clinical sciences - Abstract
ObjectiveTo describe and evaluate the use of urodynamics (UDS) studies for all indications in an academic specialty referral urology practice.Materials and methodsThis is a prospective questionnaire-based study wherein clinicians completed a pre- and post-UDS questionnaire on each UDS that they ordered for all clinical indications between May 2013 and August 2014. Questions pertained to patient demographics and history, the clinical indication for the UDS, the clinician's pre- and post-UDS clinical impressions, and changes in post-UDS management plans. Pre- and post-UDS diagnoses were compared using the McNemar test.ResultsClinicians evaluated a total of 285 UDS studies during the study period. The average age of study participants was 56.0 (±16.4) years, 59.5% were female, and 29.3% had a neurologic diagnosis. The most common indication for performing UDS was to discern the predominant type of urinary incontinence (stress vs urgency) in patients with mixed incontinence symptoms (38.5%) and to assess the safety of the bladder during filling (38.2%). UDS statistically significantly changed the ordering clinician's clinical impression of the patient's lower urinary tract diagnosis for stress urinary incontinence and for urgency and urgency urinary incontinence (both had P values of
- Published
- 2017
18. Symptom Variability and Early Symptom Regression in the MAPP Study: A Prospective Study of Urological Chronic Pelvic Pain Syndrome
- Author
-
Stephens-Shields, Alisa J, Clemens, J Quentin, Jemielita, Thomas, Farrar, John, Sutcliffe, Siobhan, Hou, Xiaoling, Landis, J Richard, Hanno, Philip, Kirkali, Ziya, Kusek, John W, Lucia, M Scott, Moldwin, Robert M, Mullins, Chris, Pontari, Michel A, Klumpp, David J, Schaeffer, Anthony J, Apkarian, Apkar, Cella, David, Farmer, Melissa A, Fitzgerald, Colleen, Gershon, Richard, Griffith, James W, Heckman, Charles J, Jiang, Mingchen, Keefer, Laurie, Marko, Darlene S, Michniewicz, Jean, Parrish, Todd, Tu, Frank, Mayer, Emeran A, Rodríguez, Larissa V, Alger, Jeffry, Ashe-McNalley, Cody P, Ellingson, Ben, Heendeniya, Nuwanthi, Kilpatrick, Lisa, Kulbacki, Cara, Kutch, Jason, Labus, Jennifer S, Naliboff, Bruce D, Randal, Fornessa, Smith, Suzanne R, Kreder, Karl J, Bradley, Catherine S, Eno, Mary, Greiner, Kris, Luo, Yi, Lutgendorf, Susan K, O’Donnell, Michael A, Ziegler, Barbara, Clauw, Daniel J, As-Sanie, Suzie, Berry, Sandra, Grayhack, Clara, Halvorson, Megan E, Harris, Richard, Harte, Steve, Ichesco, Eric, Oldendorf, Ann, Scott, Katherine A, Williams, David A, Buchwald, Dedra, Afari, Niloofar, Krieger, John, Miller, Jane, Richey, Stephanie, Robertson, Kelly, Ross, Susan O, Spiro, Roberta, Sundsvold, TJ, Strachan, Eric, Yang, Claire C, Andriole, Gerald L, Lai, H Henry, Bristol, Rebecca L, Colditz, Graham, Deutsch, Georg, Gardner, Vivien C, Gereau, Robert W, Henderson, Jeffrey P, Hong, Barry A, Hooton, Thomas M, Ness, Timothy J, North, Carol S, Spitznagle, Theresa M, Anger, Jennifer, Freeman, Michael, Kim, Jayoung, Eilber, Karyn, Van Eyk, Jennifer, Yang, Wei, Funari, Vincent, Cha, Jeena, and Barrell, Ted
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Chronic Pain ,Pain Research ,Clinical Research ,Urologic Diseases ,Adult ,Female ,Humans ,Male ,Prospective Studies ,Prostatitis ,Symptom Assessment ,Time Factors ,MAPP Research Network ,cystitis ,epidemiologic research design ,interstitial ,pain ,prostate ,symptom assessment - Abstract
PurposeWe examined symptom variability in men and women with urological chronic pelvic pain syndrome. We describe symptom fluctuations as related to early symptom regression and its effect on estimated 1-year symptom change. We also describe a method to quantify patient specific symptom variability.Materials and methodsSymptoms were assessed biweekly in 424 subjects with urological chronic pelvic pain syndrome during 1 year. To evaluate the impact of early symptom regression subjects were classified as improved, no change or worse according to the rate of change using 1) all data, 2) excluding week 0 and 3) excluding weeks 0 and 2. Patient specific, time varying variability was calculated at each interval using a sliding window approach. Patients were classified as high, medium or low variability at each time and ultimately as high or low variability overall based on the variability for the majority of contacts.ResultsPrior to excluding early weeks to adjust for early symptom regression 25% to 38% and 5% to 6% of patients were classified as improved and worse, respectively. After adjustment the percent of patients who were improved or worse ranged from 15% to 25% and 6% to 9%, respectively. High and low variability phenotypes were each identified in 25% to 30% of participants.ConclusionsPatients with urological chronic pelvic pain syndrome show symptom variability. At study enrollment patients had worse symptoms on average, resulting in a regression effect that influenced the estimated proportion of those who were improved or worse. Prospective studies should include a run-in period to account for regression to the mean and other causes of early symptom regression. Further, symptom variability may be quantified and used to characterize longitudinal symptom profiles of urological chronic pelvic pain syndrome.
- Published
- 2016
19. Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC
- Author
-
Lenherr, Sara M, Clemens, J Quentin, Braffett, Barbara H, Cleary, Patricia A, Dunn, Rodney L, Hotaling, James M, Jacobson, Alan M, Kim, Catherine, Herman, William, Brown, Jeanette S, Wessells, Hunter, Sarma, Aruna V, Nathan, DM, Zinman, B, Crofford, O, Genuth, S, Brown-Friday, J, Crandall, J, Engel, H, Engel, S, Martinez, H, Phillips, M, Reid, M, Shamoon, H, Sheindlin, J, Gubitosi-Klug, R, Mayer, L, Pendegast, S, Zegarra, H, Miller, D, Singerman, L, Smith-Brewer, S, Novak, M, Quin, J, Genuth, Saul, Palmert, M, Brown, E, McConnell, J, Pugsley, P, Crawford, P, Dahms, W, Brillon, D, Lackaye, ME, Kiss, S, Chan, R, Orlin, A, Rubin, M, Reppucci, V, Lee, T, Heinemann, M, Chang, S, Levy, B, Jovanovic, L, Richardson, M, Bosco, B, Dwoskin, A, Hanna, R, Barron, S, Campbell, R, Bhan, A, Kruger, D, Jones, JK, Edwards, PA, Carey, JD, Angus, E, Thomas, A, Galprin, A, McLellan, M, Whitehouse, F, Bergenstal, R, Johnson, M, Gunyou, K, Thomas, L, Laechelt, J, Hollander, P, Spencer, M, Kendall, D, Cuddihy, R, Callahan, P, List, S, Gott, J, Rude, N, Olson, B, Franz, M, Castle, G, Birk, R, Nelson, J, Freking, D, Gill, L, Mestrezat, W, Etzwiler, D, Morgan, K, Aiello, LP, Golden, E, Arrigg, P, Asuquo, V, Beaser, R, Bestourous, L, and Cavallerano, J
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Infectious Diseases ,Clinical Research ,Urologic Diseases ,Diabetes ,Prevention ,Reproductive health and childbirth ,Renal and urogenital ,Infection ,Metabolic and endocrine ,Adolescent ,Adult ,Blood Glucose ,Body Mass Index ,Diabetes Mellitus ,Type 1 ,Female ,Glycated Hemoglobin ,Humans ,Hypoglycemic Agents ,Risk Factors ,Surveys and Questionnaires ,Urinary Incontinence ,Urinary Tract Infections ,Young Adult ,DCCT/EDIC Research Group ,diabetes mellitus ,risk factors ,urinary tract infections ,Clinical Sciences ,Urology & Nephrology ,Clinical sciences - Abstract
PurposeWe examined the relationship between glycemic control and urinary tract infections in women with type 1 diabetes mellitus.Materials and methodsWomen enrolled in the Epidemiology of Diabetes Interventions and Complications study, the observational followup of the Diabetes Control and Complications Trial, were surveyed to assess the rate of physician diagnosed urinary tract infections in the preceding 12 months. The relationship between glycated hemoglobin levels and number of urinary tract infections in the previous 12 months was assessed using a multivariable Poisson regression model.ResultsA total of 572 women were evaluated at year 17. Mean age was 50.7 ± 7.2 years, mean body mass index was 28.6 ± 5.9 kg/m(2), mean type 1 diabetes duration was 29.8 ± 5.0 years and mean glycated hemoglobin was 8.0% ± 0.9%. Of these women 86 (15.0%) reported at least 1 physician diagnosed urinary tract infection during the last 12 months. Higher glycated hemoglobin levels were significantly associated with number of urinary tract infections such that for every unit increase (1%) in recent glycated hemoglobin level, there was a 21% (p=0.02) increase in urinary tract infection frequency in the previous 12 months after adjusting for race, hysterectomy status, urinary incontinence, sexual activity in the last 12 months, peripheral and autonomic neuropathy, and nephropathy.ConclusionsThe frequency of urinary tract infections increases with poor glycemic control in women with type 1 diabetes. This relationship is independent of other well described predictors of urinary tract infections and suggests that factors directly related to glycemic control may influence the risk of lower urinary tract infections.
- Published
- 2016
20. The Near-future Impact of Retirement on the Urologic Workforce: Results From the American Urological Association Census
- Author
-
Gaither, Thomas W, Awad, Mohannad A, Fang, Raymond, Clemens, J Quentin, Meeks, William, Gulig, Scott, Erickson, Bradley A, McKenna, Patrick H, Gonzalez, Christopher M, Osterberg, E Charles, and Breyer, Benjamin N
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Urologic Diseases ,Basic Behavioral and Social Science ,Clinical Research ,Behavioral and Social Science ,Aging ,Adult ,Aged ,Attitude of Health Personnel ,Censuses ,Female ,Forecasting ,Humans ,Male ,Middle Aged ,Retirement ,Self Report ,Societies ,Medical ,Time Factors ,United States ,Urology ,Workforce ,Urology & Nephrology ,Clinical sciences - Abstract
ObjectiveTo assess self-perceived planned retirement patterns among urologists by using the American Urological Association Census Data. With an expanding elderly population and an aging urologic workforce, concerns regarding increased demand and decreased supply of urologists have been raised.Materials and methodsWe analyzed data from the 2014 American Urological Association Census, which is a specialty representative survey distributed to the urologists who practice in the United States. A total of 2204 census samples were weighted to represent 11,703 urologists who practiced in the United States in 2014. We compared urologists who are nearing retirement (within 5 years of their planned retirement) with the rest of urologists on their demographic, geographic, and practice characteristics.ResultsOf the 11,703 practicing urologists in the United States, 3181 (95% confidence interval: 2884-3479) or 27% (95% confidence interval: 25%-30%) are nearing planned retirement. The mean age (standard deviation [SD]) of urologists nearing retirement (69, SD = 8.2) was older than nonretiring urologists (48, SD = 10.3), P
- Published
- 2016
21. Incidence and Management of Uncomplicated Recurrent Urinary Tract Infections in a National Sample of Women in the United States
- Author
-
Suskind, Anne M, Saigal, Christopher S, Hanley, Janet M, Lai, Julie, Setodji, Claude M, Clemens, J Quentin, and Project, Urologic Diseases of America
- Subjects
Reproductive Medicine ,Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Research ,Infectious Diseases ,Urologic Diseases ,Renal and urogenital ,Adolescent ,Adult ,Anti-Bacterial Agents ,Cohort Studies ,Female ,Humans ,Incidence ,Middle Aged ,United States ,Urinary Tract Infections ,Young Adult ,Urologic Diseases of America Project ,Clinical Sciences ,Urology & Nephrology ,Clinical sciences - Abstract
ObjectiveTo determine the incidence and characteristics of women with uncomplicated recurrent urinary tract infections (UTIs) and to explore whether the use of culture-driven treatment affects rates of UTI-related complications and resource utilization.Materials and methodsUsing MarketScan claims from 2003 to 2011, we identified UTI-naive women ages 18-64 with incident-uncomplicated recurrent UTIs. Recurrent UTIs were defined as 3 UTI visits associated with antibiotics during a 12-month period. Cases were excluded if they had a UTI in the preceding year, or if they had any complicating factors (eg, abnormality of the urinary tract, neurologic condition, pregnancy, diabetes, or currently taking immunosuppression). We next assessed use of urine cultures, imaging, and cystoscopy, and performed propensity score matching with logistic regression to determine whether having a urine culture associated with >50% of UTIs affected rates of complications and downstream resource utilization.ResultsWe identified 48,283 women with incident-uncomplicated recurrent UTIs, accounting for an overall incidence of 102 per 100,000 women, highest among women ages 18-34 and 55-64. Sixty-one percent of these women had at least 1 urine culture, 6.9% had imaging, and 2.8% had cystoscopy. Having a urine culture >50% of the time was associated with fewer UTI-related hospitalizations and lower rates of intravenous antibiotic use, whereas demonstrating higher rates of UTI-related office visits and pyelonephritis.ConclusionThe incidence of uncomplicated recurrent UTIs increases with age. Urine culture-directed care is beneficial in reducing high-cost services including UTI-related hospitalizations and intravenous antibiotic use, making urine cultures a valuable component to management of these patients.
- Published
- 2016
22. Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research Network
- Author
-
Griffith, James W, Stephens-Shields, Alisa J, Hou, Xiaoling, Naliboff, Bruce D, Pontari, Michel, Edwards, Todd C, Williams, David A, Clemens, J Quentin, Afari, Niloofar, Tu, Frank, Lloyd, R Brett, Patrick, Donald L, Mullins, Chris, Kusek, John W, Sutcliffe, Siobhan, Hong, Barry A, Lai, H Henry, Krieger, John N, Bradley, Catherine S, Kim, Jayoung, and Landis, J Richard
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Neurosciences ,Interstitial Cystitis ,Urologic Diseases ,Pain Research ,Clinical Research ,Chronic Pain ,Renal and urogenital ,Adult ,Aged ,Aged ,80 and over ,Biomedical Research ,Cystitis ,Interstitial ,Depression ,Female ,Humans ,Male ,Middle Aged ,Pain Measurement ,Patient Care Team ,Pelvic Pain ,Psychometrics ,Surveys and Questionnaires ,Symptom Assessment ,Young Adult ,urinary bladder ,prostatitis ,cystitis ,interstitial ,chronic pain ,factor analysis ,statistical - Abstract
PurposeThe purpose of this study was to create symptom indexes, that is scores derived from questionnaires to accurately and efficiently measure symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome, collectively referred to as urological chronic pelvic pain syndromes. We created these indexes empirically by investigating the structure of symptoms using exploratory factor analysis.Materials and methodsAs part of the MAPP (Multi-Disciplinary Approach to the Study of Chronic Pelvic Pain) Research Network 424 participants completed questionnaires, including GUPI (Genitourinary Pain Index), ICSI (Interstitial Cystitis Symptom Index) and ICPI (Interstitial Cystitis Problem Index). Individual items from questionnaires about bladder and pain symptoms were evaluated by principal component and exploratory factor analyses to identify indexes with fewer questions to comprehensively quantify symptom severity. Additional analyses included correlating symptom indexes with symptoms of depression, which is a known comorbidity of patients with pelvic pain.Results and conclusionsExploratory factor analyses suggested that the 2 factors pain severity and urinary severity provided the best psychometric description of items in GUPI, ICSI and ICPI. These factors were used to create 2 symptom indexes for pain and urinary symptoms. Pain, but not urinary symptoms, was associated with symptoms of depression on multiple regression analysis, suggesting that these symptoms may impact patients with urological chronic pelvic pain syndromes differently (B ± SE for pain severity = 0.24 ± 0.04, 95% CI 0.16-0.32, β = 0.32, p
- Published
- 2016
23. Health policy 2016
- Author
-
Suskind, Anne M and Clemens, J Quentin
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Aging ,Clinical Research ,Health Services ,Patient Safety ,Health and social care services research ,8.1 Organisation and delivery of services ,8.3 Policy ,ethics ,and research governance ,Generic health relevance ,Quality Education ,Good Health and Well Being ,Biomedical Research ,Delivery of Health Care ,Geriatrics ,Health Policy ,Health Workforce ,Quality of Health Care ,Urology ,healthcare reform ,medicare ,quality of care ,Public Health and Health Services ,Urology & Nephrology ,Clinical sciences - Abstract
Purpose of reviewThe US healthcare system is undergoing fundamental changes in an effort to improve access to care, curtail healthcare spending, and improve quality of care. These efforts largely focused on Medicare, and therefore, will have a fundamental impact on the care of geriatric patients. This article reviews contemporary health policy issues, with a focus on how these issues may impact the care of geriatric urology patients.Recent findingsThe Affordable Care Act has broadened the scope of Medicare coverage. Future Medicare reimbursement will be increasingly tied to care coordination, quality reporting, and demonstration of appropriate outcomes. Additional research is needed to better define the comparative effectiveness of urologic therapies in geriatric patients. Workforce projections indicate that there is a shortage of urologists in many areas of the country, and that this shortage will worsen over time unless a new funding model is instituted for graduate medical education.SummaryMedicare spending drives many health policy decisions. Therefore, few health policy topics are unique to geriatrics or geriatric urology. However, certain health policy topics (e.g., care coordination and risk-stratification) are particularly germaine to the elderly patients. Urologists with a particular interest in geriatric urology should be familiar with these issues.
- Published
- 2016
24. Infection and Inflammation of the Genitourinary Tract
- Author
-
Clemens, J. Quentin, primary
- Published
- 2023
- Full Text
- View/download PDF
25. Physician Use of Sacral Neuromodulation Among Medicare Beneficiaries With Overactive Bladder and Urinary Retention
- Author
-
Suskind, Anne M, Clemens, J Quentin, Zhang, Yun, and Hollenbeck, Brent K
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Urologic Diseases ,Aged ,Electric Stimulation Therapy ,Electrodes ,Implanted ,Fee-for-Service Plans ,Female ,Humans ,Lumbosacral Plexus ,Medicare ,Middle Aged ,Retrospective Studies ,United States ,Urinary Bladder ,Overactive ,Urinary Retention ,Urology & Nephrology ,Clinical sciences - Abstract
ObjectiveTo identify physician-level factors associated with high rates of sacral neuromodulation testing.Materials and methodsWe performed a retrospective cohort study using a 20% sample of national Medicare claims to identify physicians who performed sacral neuromodulation procedures between 2005 and 2010. Physician-level rates of device testing were determined based on the number of patients seen for overactive bladder and urinary retention diagnoses in the office in each calendar year. These rates were then used to fit a Poisson model to examine factors associated with high rates of device testing.ResultsThe number of physicians performing test procedures increased 4-fold from 2005 to 2010. Average rates of test procedures increased from 4.0 to 6.4 procedures per physician per year (P
- Published
- 2015
26. Relationship between Chronic Nonurological Associated Somatic Syndromes and Symptom Severity in Urological Chronic Pelvic Pain Syndromes: Baseline Evaluation of the MAPP Study
- Author
-
Krieger, John N, Stephens, Alisa J, Landis, J Richard, Clemens, J Quentin, Kreder, Karl, Lai, H Henry, Afari, Niloofar, Rodríguez, Larissa, Schaeffer, Anthony, Mackey, Sean, Andriole, Gerald L, Williams, David A, Hanno, Philip, Kirkali, Ziya, Kusek, John W, Lucia, M Scott, Mullins, Chris, Pontari, Michel A, Klumpp, David J, Schaeffer, Anthony J, Apkarian, Apkar, Cella, David, Farmer, Melissa A, Fitzgerals, Colleen, Gershon, Richard, Griffith, James W, Heckman, Charles J, Jiang, Mingchen, Keeper, Laurie, Parrish, Todd, Tu, Frank, Marko, Darlene S, Mayer, Emeran A, Rodríguez, Larissa V, Alger, Jeffry, Ashe-McNalley, Cody P, Ellingson, Ben, Kilpatrick, Lisa, Kutch, Jason, Labus, Jennifer S, Naliboff, Bruce D, Heendeniya, Nuwanthi, Randal, Fornessa, Smith, Suzanne R, Kreder, Karl J, Bradley, Catherine S, Luo, Yi, Lutgendorf, Susan K, O'Donnell, Michael A, Eno, Mary, Greiner, Kris, Ziegler, Barbara, Clauw, Daniel J, As-Sanie, Suzie, Harris, Richard, Harte, Steve, Oldendorf, Ann, Berry, Sandra, Halvorson, Megan E, Ichesco, Eric, Scott, Katherine A, Buchwald, Dedra, Krieger, John, Miller, Jane, Strachan, Eric, Yang, Claire C, Richey, Stephanie, Ross, Susan O, Spiro, Roberta, Sundsvold, TJ, Bristol, Rebecca L, Gardner, Vivien C, Colditz, Graham, Deutsch, Georg, Gereau, Robert W, Henderson, Jeffrey P, Hone, Barry A, Hooton, Thomas M, Ness, Timothy J, North, Carol S, Sutcliffe, Siobhan, Spitznagle, Theresa M, Robinson, Nancy, Stephens, Alisa, Barrell, Ted, Hou, Xiaoling, Howard, Tamara, Wang, Yanli, and van Bokhoven, Andrie
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Depression ,Urologic Diseases ,Chronic Pain ,Mental Health ,Pain Research ,Management of diseases and conditions ,7.1 Individual care needs ,Chronic Disease ,Cross-Sectional Studies ,Cystitis ,Interstitial ,Female ,Humans ,Interdisciplinary Communication ,Male ,Pelvic Pain ,Severity of Illness Index ,Surveys and Questionnaires ,Symptom Assessment ,Syndrome ,urinary bladder ,cystitis ,interstitial ,male ,female ,questionnaires ,MAPP Research Network - Abstract
PurposeWe used MAPP data to identify participants with urological chronic pelvic pain syndromes only or a chronic functional nonurological associated somatic syndrome in addition to urological chronic pelvic pain syndromes. We characterized these 2 subgroups and explored them using 3 criteria, including 1) MAPP eligibility criteria, 2) self-reported medical history or 3) RICE criteria.Materials and methodsSelf-reported cross-sectional data were collected on men and women with urological chronic pelvic pain syndromes, including predominant symptoms, symptom duration and severity, nonurological associated somatic syndrome symptoms and psychosocial factors.ResultsOf 424 participants with urological chronic pelvic pain syndromes 162 (38%) had a nonurological associated somatic syndrome, including irritable bowel syndrome in 93 (22%), fibromyalgia in 15 (4%), chronic fatigue syndrome in 13 (3%) and multiple syndromes in 41 (10%). Of 233 females 103 (44%) had a nonurological associated somatic syndrome compared to 59 of 191 males (31%) (p = 0.006). Participants with a nonurological associated somatic syndrome had more severe urological symptoms and more frequent depression and anxiety. Of 424 participants 228 (54%) met RICE criteria. Of 228 RICE positive participants 108 (47%) had a nonurological associated somatic syndrome compared to 54 of 203 RICE negative patients (28%) with a nonurological associated somatic syndrome (p < 0.001).ConclusionsNonurological associated somatic syndromes represent important clinical characteristics of urological chronic pelvic pain syndromes. Participants with a nonurological associated somatic syndrome have more severe symptoms, longer duration and higher rates of depression and anxiety. RICE positive patients are more likely to have a nonurological associated somatic syndrome and more severe symptoms. Because nonurological associated somatic syndromes are more common in women, future studies must account for this potential confounding factor in urological chronic pelvic pain syndromes.
- Published
- 2015
27. Patient Perceptions of Physical and Emotional Discomfort Related to Urodynamic Testing: A Questionnaire-based Study in Men and Women With and Without Neurologic Conditions
- Author
-
Suskind, Anne M, Clemens, J Quentin, Kaufman, Samuel R, Stoffel, John T, Oldendorf, Ann, Malaeb, Bahaa S, Jandron, Teresa, and Cameron, Anne P
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Mind and Body ,Urologic Diseases ,Aging ,Adult ,Aged ,Aged ,80 and over ,Attitude to Health ,Diagnostic Techniques ,Urological ,Emotions ,Female ,Humans ,Male ,Middle Aged ,Nervous System Diseases ,Physical Examination ,Surveys and Questionnaires ,Urodynamics ,Urology & Nephrology ,Clinical sciences - Abstract
ObjectiveTo determine predictors of physical and emotional discomfort associated with urodynamic testing in men and women both with and without neurologic conditions.MethodsAn anonymous questionnaire-based study was completed by patients immediately after undergoing fluoroscopic urodynamic testing. Participants were asked questions pertaining to their perceptions of physical and emotional discomfort related to the study, their urologic and general health history, and demographics. Logistic regression was performed to determine predictors of physical and emotional discomfort.ResultsA total of 314 patients completed the questionnaire representing a response rate of 60%. Half of the respondents (50.7%) felt that the examination was neither physically nor emotionally uncomfortable, whereas 29.0% and 12.4% of respondents felt that the physical and emotional components of the examination were most uncomfortable, respectively. Placement of the urethral catheter was the most commonly reported component of physical discomfort (42.9%), whereas anxiety (27.7%) was the most commonly reported component of emotional discomfort. Presence of a neurologic problem (odds ratio, 0.273; 95% confidence interval, 0.121-0.617) and older age (odds ratio, 0.585; 95% confidence interval, 0.405-0.847) were factors associated with less physical discomfort. There were no significant predictors of emotional discomfort based on our model.ConclusionUrodynamic studies were well tolerated regardless of gender. Presence of a neurologic condition and older age were predictors of less physical discomfort. These findings are useful in counseling patients regarding what to expect when having urodynamic procedures.
- Published
- 2015
28. Sleep disturbances and nocturnal symptoms: relationships with quality of life in a population-based sample of women with interstitial cystitis/bladder pain syndrome.
- Author
-
Troxel, Wendy M, Booth, Marika, Buysse, Daniel J, Elliott, Marc N, Suskind, Anne M, Clemens, J Quentin, and Berry, Sandra H
- Subjects
Behavioral and Social Science ,Neurosciences ,Clinical Research ,Urologic Diseases ,Chronic Pain ,Sleep Research ,Mental Health ,Interstitial Cystitis ,Pain Research ,Good Health and Well Being ,Cystitis ,Interstitial ,Female ,Humans ,Middle Aged ,Pain ,Quality of Life ,Sleep Wake Disorders ,Surveys and Questionnaires ,Syndrome ,Urinary Bladder ,pain ,bladder symptoms ,sleep quality ,sleep duration ,interstitial cystitis ,women's health ,Clinical Sciences ,Other Medical and Health Sciences ,Psychology ,Neurology & Neurosurgery - Abstract
Study objectivesTo characterize the nature and impact of sleep disturbances on quality of life (QOL) in women with interstitial cystitis/bladder pain syndrome (IC/BPS).MethodsParticipants were 3,397 women from a telephone probability survey who met IC/BPS symptom criteria. Sleep quality, duration, and IC/BPS nocturnal symptoms (i.e., trouble sleeping due to bladder pain, urgency, or needing to use the bathroom), general QOL (mental and physical health and sexual functioning), and IC/BPS QOL impairment were assessed via self-report during telephone interview.ResultsOver half of the sample reported poor sleep quality, sleep duration ≤ 6 hours, or trouble sleeping due to IC/BPS symptoms. After covariate adjustment, short sleep duration was significantly associated with greater IC/BPS QOL impairment (β = -0.04; p < 0.001) and poorer self-reported physical health (β = 1.86; p < 0.001). Poor sleep quality was significantly associated with greater IC/BPS QOL impairment (β = 0.06; p < 0.001), poorer self-reported physical health (β = -2.86; p < 0.001), and greater sexual dysfunction (β = -0.04; p < 0.05). IC/BPS nocturnal symptoms were significantly associated with greater IC/BPS impairment (β = 0.14; p < 0.001), poorer physical health (β = -2.76; p < 0.001) and mental health (β = 0.52; p < 0.01), and greater sexual dysfunction (β = -0.10; p < 0.001), after covariate adjustment. After further adjustment for IC/BPS nocturnal symptoms, we found that poor sleep quality and short sleep duration were independent correlates of poor self-reported physical health.ConclusionsPoor sleep quality and short sleep duration, as well as disorder-specific sleep disturbances, are highly prevalent in women with IC/BPS and are associated with poorer disease-specific and general QOL.
- Published
- 2014
29. Symptom persistence in a community cohort of women with interstitial cystitis/bladder pain syndrome (IC/BPS): 3-, 6-, 9-, and 12-month follow-up from the RICE cohort
- Author
-
Suskind, Anne M, Berry, Sandra H, Suttorp, Marika J, Elliott, Marc N, and Clemens, J Quentin
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Health Sciences ,Interstitial Cystitis ,Clinical Research ,Urologic Diseases ,Pain Research ,Chronic Pain ,Adult ,Aged ,Aged ,80 and over ,Cohort Studies ,Cystitis ,Interstitial ,Female ,Follow-Up Studies ,Humans ,Interviews as Topic ,Longitudinal Studies ,Middle Aged ,Prevalence ,Regression Analysis ,Symptom Assessment ,Time Factors ,United States ,Longitudinal ,Population ,Survey ,Paediatrics and Reproductive Medicine ,Obstetrics & Reproductive Medicine ,Reproductive medicine ,Midwifery - Abstract
Introduction and hypothesisThe persistence of interstitial cystitis/bladder pain syndrome (IC/BPS) symptoms has been described in women seeking medical care. The purpose of this study was to determine whether symptoms persist among a population-based sample of women.MethodsA probability sample of US women was identified through a two-stage telephone screening process using the Research and Development (RAND) Interstitial Cystitis Epidemiology (RICE) high-sensitivity case definition. A randomly selected subgroup (n = 508) was enrolled in a longitudinal study and interviewed about their symptoms at baseline, 3, 6, 9, and 12 months. Bivariate and multivariate linear regression analyses determined predictors of persistence of symptoms over the four waves.ResultsA total of 436 women with a mean age of 47.5 years responding to all waves were included in the analysis. Forty-one percent met the RICE high-sensitivity case definition at baseline and in all four waves; an additional 21 % met the definition at baseline and in three waves. Women with a college degree (+12 % vs. no college, p = 0.02) and who were younger (-5 % per decade of age, p
- Published
- 2014
30. The MAPP research network: a novel study of urologic chronic pelvic pain syndromes
- Author
-
Clemens, J Quentin, Mullins, Chris, Kusek, John W, Kirkali, Ziya, Mayer, Emeran A, Rodríguez, Larissa V, Klumpp, David J, Schaeffer, Anthony J, Kreder, Karl J, Buchwald, Dedra, Andriole, Gerald L, Lucia, M Scott, Landis, J Richard, Clauw, Daniel J, and The MAPP Research Network Study Group
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Interstitial Cystitis ,Clinical Research ,Pain Research ,Chronic Pain ,Urologic Diseases ,2.1 Biological and endogenous factors ,Aetiology ,Renal and urogenital ,Biomedical Research ,Chronic Disease ,Cystitis ,Interstitial ,Humans ,Interdisciplinary Communication ,Male ,National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) ,Pelvic Pain ,Prostatitis ,Syndrome ,United States ,Urological chronic pelvic pain syndromes ,Interstitial cystitis ,Chronic prostatitis ,Translational research ,Multi-disciplinary ,MAPP Research Network Study Group ,Urology & Nephrology ,Clinical sciences - Abstract
UnlabelledUrologic chronic pelvic pain syndrome (UCPPS) may be defined to include interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). The hallmark symptom of UCPPS is chronic pain in the pelvis, urogenital floor, or external genitalia often accompanied by lower urinary tract symptoms. Despite numerous past basic and clinical research studies there is no broadly identifiable organ-specific pathology or understanding of etiology or risk factors for UCPPS, and diagnosis relies primarily on patient reported symptoms. In addition, there are no generally effective therapies. Recent findings have, however, revealed associations between UCPPS and "centralized" chronic pain disorders, suggesting UCPPS may represent a local manifestation of more widespread pathology in some patients. Here, we describe a new and novel effort initiated by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the U.S. National Institutes of Health (NIH) to address the many long standing questions regarding UCPPS, the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. The MAPP Network approaches UCPPS in a systemic manner, in which the interplay between the genitourinary system and other physiological systems is emphasized. The network's study design expands beyond previous research, which has primarily focused on urologic organs and tissues, to utilize integrated approaches to define patient phenotypes, identify clinically-relevant subgroups, and better understand treated natural history and pathophysiology. Thus, the MAPP Network provides an unprecedented, multi-layered characterization of UCPPS. Knowledge gained is expected to provide important insights into underlying pathophysiology, a foundation for better segmenting patients for future clinical trials, and ultimately translation into improved clinical management. In addition, the MAPP Network's integrated multi-disciplinary research approach may serve as a model for studies of urologic and non-urologic disorders that have proven refractory to past basic and clinical study.Trial registrationClinicalTrials.gov identifier: NCT01098279 "Chronic Pelvic Pain Study of Individuals with Diagnoses or Symptoms of Interstitial Cystitis and/or Chronic Prostatitis (MAPP-EP)".
- Published
- 2014
31. The MAPP research network: design, patient characterization and operations
- Author
-
Landis, J Richard, Williams, David A, Lucia, M Scott, Clauw, Daniel J, Naliboff, Bruce D, Robinson, Nancy A, van Bokhoven, Adrie, Sutcliffe, Siobhan, Schaeffer, Anthony J, Rodriguez, Larissa V, Mayer, Emeran A, Lai, H Henry, Krieger, John N, Kreder, Karl J, Afari, Niloofar, Andriole, Gerald L, Bradley, Catherine S, Griffith, James W, Klumpp, David J, Hong, Barry A, Lutgendorf, Susan K, Buchwald, Dedra, Yang, Claire C, Mackey, Sean, Pontari, Michel A, Hanno, Philip, Kusek, John W, Mullins, Chris, Clemens, J Quentin, and The MAPP Research Network Study Group
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Fibromyalgia ,Pain Research ,Chronic Pain ,Clinical Research ,Urologic Diseases ,Women's Health ,Neurosciences ,2.1 Biological and endogenous factors ,Good Health and Well Being ,Biomedical Research ,Chronic Disease ,Cystitis ,Interstitial ,Female ,Humans ,Interdisciplinary Communication ,Longitudinal Studies ,Male ,National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) ,Pelvic Pain ,Phenotype ,Prospective Studies ,Prostatitis ,Research Design ,Syndrome ,United States ,Urologic chronic pelvic pain syndromes ,Interstitial cystitis ,Chronic prostatitis ,Urine biomarkers ,Plasma biomarkers ,Non-urologic associated syndromes ,Quantitative sensory testing ,Neuroimaging ,MAPP Research Network Study Group ,Urology & Nephrology ,Clinical sciences - Abstract
BackgroundThe "Multidisciplinary Approach to the Study of Chronic Pelvic Pain" (MAPP) Research Network was established by the NIDDK to better understand the pathophysiology of urologic chronic pelvic pain syndromes (UCPPS), to inform future clinical trials and improve clinical care. The evolution, organization, and scientific scope of the MAPP Research Network, and the unique approach of the network's central study and common data elements are described.MethodsThe primary scientific protocol for the Trans-MAPP Epidemiology/Phenotyping (EP) Study comprises a multi-site, longitudinal observational study, including bi-weekly internet-based symptom assessments, following a comprehensive in-clinic deep-phenotyping array of urological symptoms, non-urological symptoms and psychosocial factors to evaluate men and women with UCPPS. Healthy controls, matched on sex and age, as well as "positive" controls meeting the non-urologic associated syndromes (NUAS) criteria for one or more of the target conditions of Fibromyalgia (FM), Chronic Fatigue Syndrome (CFS) or Irritable Bowel Syndrome (IBS), were also evaluated. Additional, complementary studies addressing diverse hypotheses are integrated into the Trans-MAPP EP Study to provide a systemic characterization of study participants, including biomarker discovery studies of infectious agents, quantitative sensory testing, and structural and resting state neuroimaging and functional neurobiology studies. A highly novel effort to develop and assess clinically relevant animal models of UCPPS was also undertaken to allow improved translation between clinical and mechanistic studies. Recruitment into the central study occurred at six Discovery Sites in the United States, resulting in a total of 1,039 enrolled participants, exceeding the original targets. The biospecimen collection rate at baseline visits reached nearly 100%, and 279 participants underwent common neuroimaging through a standardized protocol. An extended follow-up study for 161 of the UCPPS participants is ongoing.DiscussionThe MAPP Research Network represents a novel, comprehensive approach to the study of UCPPS, as well as other concomitant NUAS. Findings are expected to provide significant advances in understanding UCPPS pathophysiology that will ultimately inform future clinical trials and lead to improvements in patient care. Furthermore, the structure and methodologies developed by the MAPP Network provide the foundation upon which future studies of other urologic or non-urologic disorders can be based.Trial registrationClinicalTrials.gov identifier: NCT01098279 "Chronic Pelvic Pain Study of Individuals with Diagnoses or Symptoms of Interstitial Cystitis and/or Chronic Prostatitis (MAPP-EP)". http://clinicaltrials.gov/show/NCT01098279.
- Published
- 2014
32. Symptom Based Clustering of Women in the LURN Observational Cohort Study
- Author
-
Andreev, Victor P., Liu, Gang, Yang, Claire C., Smith, Abigail R., Helmuth, Margaret E., Wiseman, Jonathan B., Merion, Robert M., Weinfurt, Kevin P., Cameron, Anne P., Lai, H. Henry, Cella, David, Gillespie, Brenda W., Helfand, Brian T., Griffith, James W., DeLancey, John O.L., Fraser, Matthew O., Clemens, J. Quentin, and Kirkali, Ziya
- Published
- 2018
- Full Text
- View/download PDF
33. Burnout in Urology: Findings from the 2016 AUA Annual Census
- Author
-
North, Amanda C., McKenna, Patrick H., Fang, Raymond, Sener, Alp, McNeil, Brian Keith, Franc-Guimond, Julie, Meeks, William D., Schlossberg, Steven M., Gonzalez, Christopher, and Clemens, J. Quentin
- Published
- 2018
- Full Text
- View/download PDF
34. Mental Health, Sleep and Physical Function in Treatment Seeking Women with Urinary Incontinence
- Author
-
Siddiqui, Nazema Y., Wiseman, Jonathan B., Cella, David, Bradley, Catherine S., Lai, H. Henry, Helmuth, Margaret E., Smith, Abigail R., Griffith, James W., Amundsen, Cindy L., Kenton, Kimberly S., Clemens, J. Quentin, Kreder, Karl J., Merion, Robert M., Kirkali, Ziya, Kusek, John W., and Cameron, Anne P.
- Published
- 2018
- Full Text
- View/download PDF
35. Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
- Author
-
Dray, Elizabeth, Cameron, Anne Pelletier, Clemens, J. Quentin, Qin, Yongmei, Covalschi, Diana, and Stoffel, John
- Published
- 2018
- Full Text
- View/download PDF
36. Validation of a simple body map to measure widespread pain in urologic chronic pelvic pain syndrome: A MAPP Research Network study.
- Author
-
Clemens, J. Quentin, Locke, Kenneth, Landis, J. Richard, Kreder, Karl, Rodriguez, Larissa V., Yang, Claire C., Tu, Frank F., Harte, Steven E., Schrepf, Andrew, Farrar, John T., Sutcliffe, Siobhan, Naliboff, Bruce D., Williams, David A., Afari, Niloofar, Spitznagle, Theresa, Taple, Bayley J., and Lai, H. Henry
- Subjects
PELVIC pain ,FIBROMYALGIA ,PAIN measurement ,CHRONIC pain ,PSYCHOSOCIAL functioning ,PAIN threshold - Abstract
Purpose: In patients with urologic chronic pelvic pain syndrome (UCPPS), the presence of widespread pain appears to identify a distinct phenotype, with a different symptom trajectory and potentially different response to treatment than patients with pelvic pain only. Materials and Methods: A 76‐site body map was administered four times, at weekly intervals, to 568 male and female UCPPS participants in the MAPP Network protocol. The 76 sites were classified into 13 regions (1 pelvic region and 12 nonpelvic regions). The degree of widespread pain was scored from 0 to 12 based on the number of reported nonpelvic pain regions. This continuous body map score was regressed over other measures of widespread pain, with UCPPS symptom severity, and with psychosocial variables to measure level of association. These models were repeated using an updated body map score (0–12) that incorporated a threshold of pain ≥ 4 at each site. Results: Body map scores showed limited variability over the 4 weekly assessments, indicating that a single baseline assessment was sufficient. The widespread pain score correlated highly with other measures of widespread pain and correlated with worsened UCPPS symptom severity and psychosocial functioning. Incorporating a pain severity threshold ≥4 resulted in only marginal increases in these correlations. Conclusions: These results support the use of this 13‐region body map in the baseline clinical assessment of UCPPS patients. It provides reliable data about the presence of widespread pain and does not require measurement of pain severity, making it relatively simple to use for clinical purposes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Understanding the Dissemination of Sacral Neuromodulation
- Author
-
Suskind, Anne M, Dunn, Rodney L, Kaufman, Samuel R, DeLancey, John OL, Clemens, J Quentin, Stoffel, John T, and Hollenbeck, Brent K
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Adolescent ,Adult ,Aged ,Aged ,80 and over ,Electric Stimulation Therapy ,Electrodes ,Implanted ,Female ,Humans ,Male ,Middle Aged ,Prostheses and Implants ,Retrospective Studies ,Sacrum ,Urinary Bladder ,Overactive ,Young Adult ,urology ,evidence-based medicine/surgery ,technology ,Design Practice and Management ,Surgery ,Clinical sciences - Abstract
ObjectivesTo assess trends in the use of sacral neuromodulation and to measure the magnitude of variation in its use across geographic regions.MethodsWe used the State Ambulatory Surgery Database (SASD) from 2002 to 2009 from Florida to identify patients implanted with a neuromodulator. Age- and gender-adjusted rates of implantation were calculated by year and by geographic region, defined by the Hospital Service Area. The coefficient of variation was estimated to quantify the magnitude of variation for different time periods.ResultsAdjusted rates of sacral neuromodulation increased significantly from 1.1 per 100,000 population in 2002 to 10.4 per 100,000 population in 2009. The majority of cases were performed for overactive bladder. There was a very large amount of geographic variation in rates of these procedures as evidenced by the high coefficients of variation: 1.67 (2002 and 2003), 1.70 (2004 and 2005), 1.49 (2006 and 2007), and 1.05 (2008 and 2009).ConclusionsRates of sacral neuromodulation have increased dramatically over the past decade. However, these rates of utilization are highly variable across regions, with some regions performing large numbers of these procedures and other regions performing few to no procedures. This range in practice patterns may reflect medical uncertainty surrounding the role of this procedure.
- Published
- 2013
38. Patient Reported Shared Decision Making in Urology From the Surgical Consumer Assessment of Healthcare Providers and Systems (CAHPS) Survey
- Author
-
Lane, Giulia I., Ellimoottil, Chad, Wallner, Lauren, Lenherr, Sara, and Clemens, J. Quentin
- Published
- 2020
- Full Text
- View/download PDF
39. Autologous Fascial Slings
- Author
-
Barboglio Romo, Paholo G., Clemens, J. Quentin, Klein, Eric A., Series editor, and Goldman, Howard B., editor
- Published
- 2017
- Full Text
- View/download PDF
40. Correlates of Health Care Seeking Activities in Patients with Urological Chronic Pelvic Pain Syndromes: Findings from the MAPP Cohort
- Author
-
Clemens, J. Quentin, Stephens-Shields, Alisa, Naliboff, Bruce D., Lai, H. Henry, Rodriguez, Larissa, Krieger, John N., Williams, David A., Kusek, John W., and Landis, J. Richard
- Published
- 2018
- Full Text
- View/download PDF
41. A Case-Crossover Study of Urological Chronic Pelvic Pain Syndrome Flare Triggers in the MAPP Research Network
- Author
-
Sutcliffe, Siobhan, Jemielita, Thomas, Lai, H. Henry, Andriole, Gerald L., Bradley, Catherine S., Clemens, J. Quentin, Gallop, Robert, Hooton, Thomas M., Kreder, Karl J., Krieger, John N., Kusek, John W., Labus, Jennifer, Lucia, M. Scott, Mackey, Sean, Naliboff, Bruce D., Robinson, Nancy A., Rodriguez, Larissa V., Stephens-Shields, Alisa, van Bokhoven, Adrie, Wolin, Kathleen Y., Yan, Yan, Yang, Claire C., Landis, J. Richard, and Colditz, Graham A.
- Published
- 2018
- Full Text
- View/download PDF
42. Baseline Lower Urinary Tract Symptoms in Patients Enrolled in LURN: A Prospective, Observational Cohort Study
- Author
-
Cameron, Anne P., Lewicky-Gaupp, Christina, Smith, Abigail R., Helfand, Brian T., Gore, John L., Clemens, J. Quentin, Yang, Claire C., Siddiqui, Nazema Y., Lai, H. Henry, Griffith, James W., Andreev, Victor P., Liu, Gang, Weinfurt, Kevin, Amundsen, Cindy L., Bradley, Catherine S., Kusek, John W., and Kirkali, Ziya
- Published
- 2018
- Full Text
- View/download PDF
43. Health-related quality of life in patients with interstitial cystitis/bladder pain syndrome and frequently associated comorbidities
- Author
-
Suskind, Anne M, Berry, Sandra H, Suttorp, Marika J, Elliott, Marc N, Hays, Ron D, Ewing, Brett A, and Clemens, J Quentin
- Subjects
Health Sciences ,Behavioral and Social Science ,Urologic Diseases ,Pain Research ,Interstitial Cystitis ,Clinical Research ,Chronic Pain ,Management of diseases and conditions ,7.1 Individual care needs ,Good Health and Well Being ,Adult ,Aged ,Comorbidity ,Cystitis ,Interstitial ,Fatigue Syndrome ,Chronic ,Female ,Fibromyalgia ,Health Status ,Health Surveys ,Humans ,Interviews as Topic ,Irritable Bowel Syndrome ,Male ,Middle Aged ,Quality of Life ,Regression Analysis ,Self Report ,Chronic fatigue syndrome ,Irritable bowel syndrome ,Quality of life ,Public Health and Health Services ,Psychology ,Health Policy & Services ,Health sciences ,Human society - Abstract
PurposeTo estimate the association of chronic non-urologic conditions [i.e., fibromyalgia (FM), chronic fatigue syndrome (CFS), and irritable bowel syndrome (IBS)] with health-related quality of life (HRQOL) in patients with interstitial cystitis/bladder pain syndrome (IC/BPS).MethodsA total of 276 women with established diagnoses of IC/BPS completed a telephone interview which included demographics, self-reported medical conditions, the SF-36 health survey, and the interstitial cystitis symptom index (ICSI). Multivariate linear regression analysis was used to identify correlates of SF-36 physical and mental component summary scores.ResultsMean patient age was 45.1 (SD 15.9) years, and 83% of the subjects were white. Mean values for the SF-36 Physical Component Score (PCS) and Mental Component Score (MCS) means were 39 (SD 14) and 45 (SD 12), respectively, indicating significant HRQOL reductions. Mean ICSI score was 11.27 (SD = 4.86). FM and IBS were significantly associated with worse SF-36 scores: -8 points on the PCS (p < 0.001) and -6 points on the MCS (p < 0.001). CFS and the presence of other pelvic conditions (overactive bladder, vulvodynia, endometriosis) were not significantly associated with SF-36 PCS and MCS scores.ConclusionsIn patients with IC/BPS, the presence of FM, CFS, and IBS has a significant association with HRQOL, equivalent in impact to the bladder symptoms themselves. These results emphasize the importance of a multidisciplinary approach to treating patients with IC/BPS and other conditions.
- Published
- 2013
44. Effectiveness of Mesh Compared With Nonmesh Sling Surgery in Medicare Beneficiaries
- Author
-
Suskind, Anne M, Clemens, J Quentin, Dunn, Rodney L, Zhang, Yun, Stoffel, John T, and Hollenbeck, Brent K
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Clinical Sciences ,Urologic Diseases ,Clinical Research ,Patient Safety ,6.4 Surgery ,Evaluation of treatments and therapeutic interventions ,Good Health and Well Being ,Aged ,Aged ,80 and over ,Ambulatory Surgical Procedures ,Female ,Humans ,Logistic Models ,Medicare ,Retrospective Studies ,Suburethral Slings ,Surgical Mesh ,United States ,Urinary Incontinence ,Stress ,Paediatrics and Reproductive Medicine ,Obstetrics & Reproductive Medicine ,Reproductive medicine - Abstract
ObjectiveTo assess the effectiveness of mesh compared with nonmesh slings placed in different surgical settings as measured by the frequency of complications within 1 year.MethodsWe performed a retrospective cohort study of Medicare beneficiaries undergoing sling surgery from 2006 to 2008 in hospital outpatient departments and hospital-based ambulatory surgery centers. Slings were identified and categorized according to the use of mesh by Healthcare Common Procedure Coding System codes and temporary "C" Healthcare Common Procedure Coding System codes. Patients were followed for 1 year after each procedure to identify complications. Logistic models were fit to assess relationships among sling type, surgical setting, and various complications.ResultsWe identified 6,698 Medicare beneficiaries who underwent mesh sling procedures and 445 Medicare beneficiaries who underwent nonmesh sling procedures. The overall frequency of complications was similar between the two groups at 69.8% and 72.6% in the mesh and nonmesh groups, respectively (P=.22). Infectious complications were the most common complication at 45.4% and 50.1% of the mesh and nonmesh groups, respectively (P=.06). Patients undergoing mesh procedures were less likely than patients undergoing nonmesh procedures to require management for bladder outlet obstruction (13.9% compared with 19.3%, adjusted odds ratio [OR] 0.66, 95% confidence interval [CI] 0.52-0.85) and were less likely to have a subsequent sling removal and revision or urethrolysis (2.7% compared with 4.7%, adjusted OR 0.56, 95% CI 0.35-0.89).ConclusionFrequencies of most complications were similar regardless of the use of mesh except for the management of bladder outlet obstruction. These results did not differ based on the surgical setting where the sling procedure was performed.Level of evidenceII.
- Published
- 2013
45. The Prevalence and Overlap of Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Men: Results of the RAND Interstitial Cystitis Epidemiology Male Study
- Author
-
Suskind, Anne M, Berry, Sandra H, Ewing, Brett A, Elliott, Marc N, Suttorp, Marika J, and Clemens, J Quentin
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Urologic Diseases ,Chronic Pain ,Clinical Research ,Pain Research ,Interstitial Cystitis ,Adolescent ,Adult ,Aged ,Cystitis ,Interstitial ,Humans ,Male ,Middle Aged ,Prevalence ,Prostatitis ,Young Adult ,cystitis ,interstitial ,prostatitis ,epidemiology ,men ,Urology & Nephrology ,Clinical sciences - Abstract
PurposeAs part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied these case definitions to determine the prevalence of these conditions in men.Materials and methodsA total of 6,072 households were contacted by telephone to screen for men who had symptoms of interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome. An initial 296 men screened positive, of whom 149 met the inclusionary criteria and completed the telephone interview. For interstitial cystitis/bladder pain syndrome 2 case definitions were applied (1 with high sensitivity and 1 with high specificity), while for chronic prostatitis/chronic pelvic pain syndrome a single case definition (with high sensitivity and specificity) was used. These case definitions were used to classify subjects into groups based on diagnosis.ResultsThe interstitial cystitis/bladder pain syndrome weighted prevalence estimates for the high sensitivity and high specificity definitions were 4.2% (3.1-5.3) and 1.9% (1.1-2.7), respectively. The chronic prostatitis/chronic pelvic pain syndrome weighted prevalence estimate was 1.8% (0.9-2.7). These values equate to 1,986,972 (95% CI 966,042-2,996,924) men with chronic prostatitis/chronic pelvic pain syndrome and 2,107,727 (95% CI 1,240,485-2,974,969) men with the high specificity definition of interstitial cystitis/bladder pain syndrome in the United States. The overlap between men who met the high specificity interstitial cystitis/bladder pain syndrome case definition or the chronic prostatitis/chronic pelvic pain syndrome case definition was 17%.ConclusionsSymptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome are widespread among men in the United States. The prevalence of interstitial cystitis/bladder pain syndrome symptoms in men approaches that in women, suggesting that this condition may be underdiagnosed in the male population.
- Published
- 2013
46. Natural bladder filling alters resting brain function at multiple spatial scales: a proof-of-concept MAPP Network Neuroimaging Study
- Author
-
Mawla, Ishtiaq, Schrepf, Andrew, Ichesco, Eric, Harte, Steven E., Klumpp, David J., Griffith, James W., Strachan, Eric, Yang, Claire C., Lai, Henry, Andriole, Gerald, Magnotta, Vincent A., Kreder, Karl, Clauw, Daniel J., Harris, Richard E., Clemens, J. Quentin, Landis, J. Richard, Mullins, Chris, Rodriguez, Larissa V., Mayer, Emeran A., and Kutch, Jason J.
- Published
- 2020
- Full Text
- View/download PDF
47. Destroyed bladders: Characterization of progressive inflammatory cystitis
- Author
-
Faris, Anna, primary, Lane, Giulia I., additional, Mehra, Rohit, additional, Dadhania, Vipulkumar, additional, Crescenze, Iryna, additional, Clemens, J. Quentin, additional, Romo, Paholo Barboglio, additional, Stoffel, John, additional, Malaeb, Bahaa, additional, Blair, Yooni, additional, Goh, Meidee, additional, Gupta, Priyanka, additional, and Cameron, Anne P., additional
- Published
- 2023
- Full Text
- View/download PDF
48. PD14-02 WHAT INFORMS PATIENT DECISION-MAKING WHEN SELECTING TREATMENT FOR OVERACTIVE BLADDER? A MIXED METHODS STUDY OF PATIENT PREFERENCES
- Author
-
Brodsky, Casey, primary, Sitto, Hannah, additional, Wittmann, Daniela, additional, Wallner, Lauren, additional, Streur, Courtney, additional, Dejonckheere, Melissa, additional, Stoffel, John, additional, Sarma, Aruna, additional, Clemens, J. Quentin, additional, and Lane, Giulia, additional
- Published
- 2023
- Full Text
- View/download PDF
49. PD14-08 PHENOTYPING OAB PATIENTS WITH UROLOGIC OR NON-UROLOGIC PAIN – AND COMPARISON TO OAB PATIENTS WITHOUT PAIN, FINDINGS FROM THE LURN STUDY
- Author
-
Lai, H Henry, primary, Helmuth, Margaret, additional, Smith, Abigail, additional, Yang, Claire, additional, Kenton, Kimberly, additional, Bretschneider, Carol, additional, Cameron, Anne, additional, Clemens, J. Quentin, additional, Bradley, Catherine, additional, Kawasaki, Amie, additional, Kirkali, Ziya, additional, and Harte, Steven, additional
- Published
- 2023
- Full Text
- View/download PDF
50. MP19-20 UNDERSTANDING PATIENT EXPERIENCES WITH OVERACTIVE BLADDER
- Author
-
Sitto, Hannah, primary, Brodsky, Casey, additional, Wittmann, Daniela, additional, Wallner, Lauren, additional, Streur, Courtney, additional, Dejonckheere, Melissa, additional, Stoffel, John, additional, Sarma, Aruna, additional, Clemens, J. Quentin, additional, and Lane, Giulia, additional
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.